1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 21 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvementWechalekar, M.; Lester, S.; Proudman, S.; Cleland, L.; Whittle, S.; Rischmueller, M.; Hill, C.
2015Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three yearsWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2015Synovial fluid and plasma n3 long chain polyunsaturated fatty acids in patients with inflammatory arthritisMoghaddami, M.; James, M.; Proudman, S.; Cleland, L.
2015The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies - a systematic reviewMohamed, H.; Sorich, M.; Kowalski, S.; McKinnon, R.; Proudman, S.; Cleland, L.; Wiese, M.
2011Fatty acid desaturase 2 promoter mutation is not responsible for Δ6-desaturase deficiencyGregory, M.; Lester, S.; Cook-Johnson, R.; Gibson, R.; Proudman, S.; Cleland, L.; James, M.
2011Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC-MS/MSRakhila, H.; Rozek, T.; Hopkins, A.; Proudman, S.; Cleland, L.; James, M.; Wiese, M.
2012Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritisWiese, M.; Schnabl, M.; O'Doherty, C.; Spargo, L.; Sorich, M.; Cleland, L.; Proudman, S.
2012Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritisO'Doherty, C.; Schnabl, M.; Spargo, L.; Cleland, L.; James, M.; Proudman, S.; Wiese, M.
2016Effect of adherence to protocolized targeted intensifications of disease-modifying antirheumatic drugs on treatment outcomes in rheumatoid arthritis: results from an Australian early arthritis cohortWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2014Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritisWiese, M.; Alotaibi, N.; O'Doherty, C.; Sorich, M.; Suppiah, V.; Cleland, L.; Proudman, S.

Discover